Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-01

FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application to authorize Voquezna Dual Pak, a fixed-dose combination of vonoprazan fumarate and amoxicillin, for the treatment of He…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA DUAL PAK (Vonoprazan fumarate and amoxicillin)

Snippet

SUPPL AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)